We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

111 hedge funds and large institutions have $971M invested in Praxis Precision Medicines in 2024 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

729% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 7

443% more capital invested

Capital invested by funds: $179M → $971M (+$792M)

200% more funds holding in top 10

Funds holding in top 10: 3 → 9 (+6)

117% more call options, than puts

Call options by funds: $2.95M | Put options by funds: $1.36M

85% more funds holding

Funds holding: 60 → 111 (+51)

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

26.5% more ownership

Funds ownership: 93.73% → 120.24% (+27%)

Holders
111
Holders Change
+51
Holders Change %
+85%
% of All Funds
1.6%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.13%
New
58
Increased
30
Reduced
17
Closed
7
Calls
$2.95M
Puts
$1.36M
Net Calls
+$1.59M
Net Calls Change
+$1.34M

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$37.2M
2
PA
Perceptive Advisors
New York
+$36.9M
3
CAM
Cormorant Asset Management
Massachusetts
+$30.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$29.4M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M

Top Sellers

1
Bank of America
Bank of America
North Carolina
-$11.7M
2
PHS
PFM Health Sciences
California
-$8.03M
3
Verition Fund Management
Verition Fund Management
Connecticut
-$7.07M
4
SFM
Sphera Funds Management
Israel
-$6.81M
5
TLP
Tri Locum Partners
New York
-$6.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
26
Ikarian Capital
Texas
$10.3M -$1.42M -31,612 -16%
ACP
27
Acuta Capital Partners
California
$9.9M -$6.16M -137,334 -46%
ABG
28
Ally Bridge Group
New York
$9.73M +$4M +89,062 +126%
LGM
29
Logos Global Management
California
$9.15M +$6.73M +150,000 New
Franklin Resources
30
Franklin Resources
California
$8.87M +$6.52M +145,295 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$8.22M +$1.87M +41,759 +45%
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$8.11M +$4.84M +107,838 +430%
BBA
33
Baker Bros. Advisors
New York
$8.03M – – –
Marshall Wace
34
Marshall Wace
United Kingdom
$7.38M +$3.24M +72,182 +148%
TLP
35
Tri Locum Partners
New York
$6.5M -$6.38M -142,267 -57%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$6.48M +$2.6M +57,875 +120%
Morgan Stanley
37
Morgan Stanley
New York
$6.11M +$2.97M +66,270 +196%
Goldman Sachs
38
Goldman Sachs
New York
$6.02M +$4.43M +98,635 New
Invesco
39
Invesco
Georgia
$5.81M +$4.27M +95,181 New
LP
40
LMR Partners
United Kingdom
$5.76M +$4.23M +94,332 New
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
$5.67M +$4.17M +93,000 New
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
$5.02M -$709K -15,795 -16%
ACM
43
Altium Capital Management
New York
$4.77M +$3.5M +78,100 New
Assenagon Asset Management
44
Assenagon Asset Management
Luxembourg
$4.35M +$3.2M +71,253 New
7IH
45
72 Investment Holdings
Connecticut
$4.02M – – –
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$3.15M -$670K -14,940 -22%
JP Morgan Chase
47
JP Morgan Chase
New York
$3.13M +$2.3M +51,355 +302,088%
FCM
48
Farallon Capital Management
California
$3.05M +$2.24M +50,000 New
Jane Street
49
Jane Street
New York
$2.87M +$1.64M +36,490 +345%
FAM
50
Fred Alger Management
New York
$2.87M +$2.11M +47,041 New
1
2
3 4 5

PRAX Hedge Fund Activity: Q1 2024 in Review

111 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q1 2024, worth a combined $971M — up 443% from $179M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new PRAX positions and 7 closed out — a net gain of 51 holders — while 30 added to existing stakes and 17 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $37.2M. The largest seller was Bank of America, cutting an estimated $11.7M.

  • 111 institutional investors held Praxis Precision Medicines (PRAX) as of Q1 2024, up from 60 in Q4 2023.
  • Funds reported $971M of Praxis Precision Medicines stock for Q1 2024, up 443% quarter-over-quarter.
  • 58 funds opened new Praxis Precision Medicines positions in Q1 2024 and 7 closed out, a net change of +51 holders.
  • The largest Praxis Precision Medicines buyer in Q1 2024 was RA Capital Management, an estimated $37.2M added.
  • The largest Praxis Precision Medicines seller in Q1 2024 was Bank of America, an estimated $11.7M sold.

Based on aggregated 13F filings for Q1 2024.